glp 1 agonist GLP-1 receptor agonists show promise in treating substance use disorders GLP-1 Receptor Agonists Explained for

The company plans to submit for a type 2 diabetes indication in 2026 as well, with potential approval for that indication in 2027

In June 2025, the TGA issued a medicines safety update requiring consideration be given to the risk of delayed gastric emptying and aspiration when providing anaesthesia or deep sedation for patients using these drugs

During recovery phase Continue all supportive measures until regrowth is well established

But temporary does not mean trivial, especially when you are living through them

Potential Side Effects The GLP-1 receptor agonists type medications interfere with absorption and utilization of vitamins and minerals in the body which may lead to nutrient depletion, loss of muscle mass and changes in facial appearance

Together, they play a critical role in glucose homeostasis by stimulating insulin secretion following a meal